Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of TAK-385 for endometriosis
jRCT2080221548Phase 2
- Sponsor
- Takeda
- Start
- Aug 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tissue-plasminogen activator in endometriosis (4 arms), sponsored by Takeda.
02
Drugs
tissue-plasminogen activator
03
Conditions
endometriosis
Beyond the preview
Go deeper on jRCT2080221548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221548.